We are live on ! Find out more
ARDS

Aridis Pharmaceuticals Inc. Common Stock
ARDS

Delisted

ARDS was delisted on the 18th of July, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Aridis Pharmaceuticals Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $10 → $0 (-$10)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BCWM
Bartlett & Co Wealth Management
Ohio
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
BCWM
1
Bartlett & Co Wealth Management
Ohio
– -$10 -150 Closed

ARDS Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) for Q1 2024, worth a combined $0 — down 100% from $10 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ARDS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Bartlett & Co Wealth Management, exiting entirely with an estimated $10 sold.

  • 0 institutional investors held Aridis Pharmaceuticals Inc. Common Stock (ARDS) as of Q1 2024, down from 2 in Q4 2023.
  • Funds reported $0 of Aridis Pharmaceuticals Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Aridis Pharmaceuticals Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of -1 holder.
  • The largest Aridis Pharmaceuticals Inc. Common Stock seller in Q1 2024 was Bartlett & Co Wealth Management, an estimated $10 sold.

Based on aggregated 13F filings for Q1 2024.